Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
Mona Ranade, Clinical Associate Professor at Stanford University, shared on LinkedIn:
”If you’re interested in how real-world data can actually change the way we think about clinical care, this is worth a watch.
In this walkthrough, Mira M. breaks down our study on catheter-directed therapy for pulmonary embolism – from how we built the cohort to what the results really mean in practice.
She does an incredible job showing not just the findings (earlier CDT – lower 90-day costs driven by less downstream utilization), but how we were able to get there using Medeloop Analytics.
This is what stood out to me: the ability to go from a clinical question to a longitudinal, meaningful answer – fast.
And if you’ve been following along – Medeloop Health Research Case Competition wraps up May 7th at 12 PM, where winners will be announced.
Excited to see what others have built – this is just the beginning of what this kind of tooling makes possible.”
Stay updated with Hemostasis Today.
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge